Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Idusogie E"'
Autor:
Zammarchi F; ADC Therapeutics (UK) Ltd, London, United Kingdom., Havenith KE; ADC Therapeutics (UK) Ltd, London, United Kingdom., Sachini N; ADC Therapeutics (UK) Ltd, London, United Kingdom., Janghra N; ADC Therapeutics (UK) Ltd, London, United Kingdom., Chivers S; ADC Therapeutics (UK) Ltd, London, United Kingdom., Idusogie E; ADC Therapeutics America, Inc, Murray Hill, United States., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Bertelli F; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Santos K; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Tyrer P; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Corbett S; University College London, London, United Kingdom., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Hartley JA; University College London, London, United Kingdom., van Berkel PH; ADC Therapeutics (UK) Ltd, London, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Apr 02; Vol. 23 (4), pp. 520-531.
Publikováno v:
Ecology of Food & Nutrition; Jun1972, Vol. 1 Issue 3, p235-243, 9p
Autor:
Rosen ED; Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium., Chan JC, Idusogie E, Clotman F, Vlasuk G, Luther T, Jalbert LR, Albrecht S, Zhong L, Lissens A, Schoonjans L, Moons L, Collen D, Castellino FJ, Carmeliet P
Publikováno v:
Nature [Nature] 1997 Nov 20; Vol. 390 (6657), pp. 290-4.
Autor:
Idusogie E; Department of Chemistry and Biochemistry, University of Notre Dame, IN 46556, USA., Rosen ED, Carmeliet P, Collen D, Castellino FJ
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 1996 Dec; Vol. 76 (6), pp. 957-64.
Autor:
Idusogie E; Department of Chemistry and Biochemistry, University of Notre Dame, Indiana 46556, USA., Rosen E, Geng JP, Carmeliet P, Collen D, Castellino FJ
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 1996 Mar; Vol. 75 (3), pp. 481-7.
Genetic duplication of tissue factor reveals subfunctionalization in venous and arterial hemostasis.
Autor:
Grzegorski, Steven J.1 (AUTHOR), Zhao, Yakun1 (AUTHOR), Richter, Catherine E.1 (AUTHOR), Ku, Chia-Jui1 (AUTHOR), Lavik, Kari I.1 (AUTHOR), Paul, Divyani2 (AUTHOR), Morrissey, James H.2 (AUTHOR), Shavit, Jordan A.1,3 (AUTHOR) jshavit@umich.edu
Publikováno v:
PLoS Genetics. 11/30/2022, Vol. 18 Issue 11, p1-21. 21p.
Publikováno v:
Anesthesia & Analgesia; Apr2024, Vol. 138 Issue 4, p696-711, 16p
Autor:
Oostindie SC; Genmab, Utrecht, Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Lazar GA; Department of Antibody Engineering, Genentech, San Francisco, CA, USA., Schuurman J; Genmab, Utrecht, Netherlands., Parren PWHI; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands. p.parren@lavatherapeutics.com.; Sparring Bioconsult, Odijk, Netherlands. p.parren@lavatherapeutics.com.; Lava Therapeutics, Utrecht, Netherlands. p.parren@lavatherapeutics.com.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2022 Oct; Vol. 21 (10), pp. 715-735. Date of Electronic Publication: 2022 Jul 05.
Autor:
Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Scalise L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Van Berkel PH; ADC Therapeutics (UK) Ltd., London, UK., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zammarchi F; ADC Therapeutics (UK) Ltd., London, UK., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1873-1882. Date of Electronic Publication: 2024 Jul 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.